A number of animal and clinical studies have shown that BBR improves insulin resistance and obesity-induced metabolic dysregulation, mainly as a result of AMPK activation and inhibition of the inflammatory response in insulin-sensitive tissues (Kim et al., 2009; Chang et al., 2015; Belwal et al., 2020). Here, INS is linked to Obesity.